| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 76.614 | 82.313 | 94.403 | 103.440 | 108.158 | 98.828 | 111.887 | 143.127 | 172.114 | 185.588 |
| Total Income - EUR | 77.925 | 82.321 | 94.404 | 103.441 | 108.159 | 98.829 | 111.887 | 143.127 | 172.115 | 185.589 |
| Total Expenses - EUR | 61.346 | 62.770 | 62.816 | 69.824 | 78.224 | 76.592 | 84.516 | 101.776 | 115.134 | 144.281 |
| Gross Profit/Loss - EUR | 16.579 | 19.552 | 31.588 | 33.617 | 29.936 | 22.237 | 27.372 | 41.352 | 56.980 | 41.308 |
| Net Profit/Loss - EUR | 13.925 | 18.728 | 30.644 | 32.583 | 28.854 | 21.315 | 26.275 | 40.160 | 55.294 | 35.852 |
| Employees | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Biotest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.568 | 30.968 | 37.341 | 32.760 | 24.776 | 28.933 | 22.984 | 19.167 | 25.182 | 37.450 |
| Current Assets | 14.334 | 7.888 | 8.509 | 9.965 | 9.306 | 8.183 | 11.393 | 31.059 | 39.641 | 24.095 |
| Inventories | 0 | 0 | 895 | 982 | 0 | 305 | 2.495 | 2.889 | 1.974 | 3.526 |
| Receivables | 8.076 | 7.239 | 7.608 | 8.849 | 8.451 | 5.778 | 6.658 | 25.626 | 33.930 | 20.470 |
| Cash | 6.258 | 649 | 6 | 133 | 855 | 2.099 | 2.240 | 2.544 | 3.737 | 98 |
| Shareholders Funds | 38.562 | 32.984 | 33.160 | 33.172 | 28.960 | 22.677 | 26.395 | 40.553 | 55.626 | 36.101 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.340 | 5.872 | 12.690 | 9.552 | 5.121 | 14.438 | 7.982 | 9.674 | 11.466 | 25.443 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Biotest Srl